Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives - Centre d’Etude des Pathologies Respiratoires (CEPR), UMR 1100 Accéder directement au contenu
Article Dans Une Revue Vaccines Année : 2021

Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives

Résumé

Respiratorytract infections (RTIs) are frequent and life-threatening diseases, accounting for several millions of deaths worldwide. RTIs implicate microorganisms, including viruses (influenza virus, coronavirus, respiratory syncytial virus (RSV)), bacteria (Pseudomonas aeruginosa, Streptococcus pneumoniae, Staphylococcus aureus and Bacillus anthracis) and fungi (Pneumocystis spp., Aspergillus spp. and very occasionally Candida spp.). The emergence of new pathogens, like the coronavirus SARS-CoV-2, and the substantial increase in drug resistance have highlighted the critical necessity to develop novel anti-infective molecules. In this context, antibodies (Abs) are becoming increasingly important in respiratory medicine and may fulfill the unmet medical needs of RTIs. However, development of Abs for treating infectious diseases is less advanced than for cancer and inflammatory diseases. Currently, only three Abs have been marketed for RTIs, namely, against pulmonary anthrax and RSV infection, while several clinical and preclinical studies are in progress. This article gives an overview of the advances in the use of Abs for the treatment of RTIs, based on the analysis of clinical studies in this field. It describes the Ab structure, function and pharmacokinetics, and discusses the opportunities offered by the various Ab formats, Ab engineering and co-treatment strategies. Including the most recent literature, it finally highlights the strengths, weaknesses and likely future trends of a novel anti-RTI Ab armamentarium.
Fichier principal
Vignette du fichier
vaccines-1091019 GD.pdf (883.59 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03485350 , version 1 (03-06-2022)

Identifiants

Citer

Alexie Mayor, Adélaïde Chesnay, Guillaume Desoubeaux, David Ternant, Nathalie Heuzé-Vourc'H, et al.. Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives. Vaccines, 2021, 9 (2), pp.151. ⟨10.3390/vaccines9020151⟩. ⟨hal-03485350⟩
32 Consultations
155 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More